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1 Introduction
Bupivacaine is commonly used for obstetrical
epidural analgesia and this agent has been men-
tioned recently in discussions about complica-
tions of this anesthetic method. HUNTER et al
[5] reported on fetal accidents during obstetrical
epidural analgesia using bupivacaine. Because
of reports about a possible increase incidence
of hyperbilirubinemia in newborns following
delivery under epidural analgesia as well as
intoxications in newborns following adminis-
tration by apparently correct technique [16]
caused us to undertake this study. It appeared
important to investigate distribution of this lo-
cal anesthetic agent in the body.
Bupivacaine is a local anesthetic of the amide
type. Its molecular weight is 325. It is a weak
base with a pKa of 8.1. Thus the pH is impor-
tant for the degree of dissociation. Bupivacaine
has been investigated in numerous studies and
has been shown to be of low risk.
Bupivacaine levels have been investigated in
plasma as well as whole blood. The ratio of
blood to plasma concentration according to
TUCKER et al [18] is 0.73 + 0.08. The high pro-
tein binding of bupivacaine made it especially
appealing as a local anesthetic during pregnan-
cy because of the assumption that this would
result in a low placental transfer. More recent
investigations by MARX [9] have questioned this
advantage of bupivacaine over other local anes-
thetics because of a decreased plasma protein
binding capacity during pregnancy. It cannot
be ruled out that more free, and thus active
bupivacaine, is present so that under these con-
ditions the risk for complications may not be
as low as had been assumed.
2 Fetal material
We examined two fetuses following obstetrical
epidural anesthesia. Both were born alive.
Fetus M
Delivery came in the 40th gestational week (39 weeks,
5 days) following induction of labor with oxytocin and
prostaglandin F 2 because of the sonographic diagnosis
of anencephaly. Induction of labor began at about
5:00 p. m., delivery occurred at 5:00 a. m. Blood samples
for the determination of bupivacaine levels were ob-
tained at 7:00p.m., 8:00p.m., 8:40p.m., at birth;
5:20 a. m. A total dose of 125 mg bupivacaine was used
for the epidural analgesia. The infant breathed immedi-
ately and spontaneously, and it died at 21 minutes of
age. Autopsy findings: mature fetus with anencephaly,
birth weight 2790 g, length 48 cm. Cause of death: post-
partum asphyxia. The placenta weighed 700 grams.
Fetus J
Induction of labor was performed with intra-amniotic
prostaglandin F 2 in the 24th week (23 weeks + 4 days)
because of maternal intestinal carcinoma with lung
metastases. The total dose for the epidural analgesia was
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87.5 mg of bupivacaine. The infant died three minutes
after birth. The crownrump length was 29.5 cm: there
were no anomalies.
Organs and blood from these fetuses were frozen and
thawed just before the assays. Under these conditions
bupivacaine is stable.
3 Methods
The samples were analyzed with a Hewlett
Packard gas Chromatograph 5840 A. A nitrogen
sensitive detector was used; and the carrier gas
was nitrogen. The analytical limits were 11 ng/
g and 11 ng/ml in tissue and blood respectively.
The concentrations were calculated in the linear
range of the calibration curves from 5 to
lOOOng and 50 to 3000 ng respectively. In re-
gard to the reproducability of the method the
Vk was < 8.5% in the range above 65 ng/g or
ng/ml and a Vk rate of 8.5% -17.9% below the
limit concentration of 65 ng/g or ng/ml.
4 Results
4.1 Results from Fetus M
The results are depicted in detail in table I and
figure 1. The ratio of fetal to maternal blood
levels was 0.37 at the time of birth (ratio of
concentrations in umbilical venous blood and
maternal blood).
ng/ml
Table L Distribution of bupivacaine in the tissue in
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The fetal blood analysis, before birth at
8:40 p. m. was 179 ng/ml with the simultaneous
maternal venous concentration at 180 ng/ml.
This established the ratio of fetal to maternal
blood concentration as nearly 1.0.
The measurements showed a particularly high
concentration in the lungs exceeding the con-
centration of blood by a factor of 40. Concen-
tration in the heart was three times higher than
the blood while concentrations in the liver, kid-
ney, gall bladder and thymus were about double
that in the.blood. Concentration in fat was low
and in muscles only slightly above the blood
levels.
| 4.2 Results from Fetus J
Figure 1. Organ concentration of bupivacaine in Fetus
M.
The results from the organ analysis are shown
in table I and figure 2. The liver concentration
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Figure 2. Organ concentration of bupivacaine in Fetus
J.
exceeded the blood level 2 VI fold. In the brain
the concentration similar to the findings in
Fetus M was low at the level of the blood
whereas the concentration in the other organs
were slightly above that in blood.
5 Discussion
Blood levels of bupivacaine found in this study
were in ranges found by other authors [1, 12,
17]. Similarly, the ratio of fetal to maternal
concentrations was in the range found by these
authors. The distribution of bupivacaine in in-
fluenced by the differences between fetal and
adult circulation, in that the blood flows from
the placenta via the umbilical vein into the fetal
body where part of the blood perfuses the liver,
with another part flowing through the ductus
venosus directly into the vena cava. In the heart
the major portion of the blood is directed
through the patent foramen ovale into the left
atrium. The truncus pulmonalis is perfused pre-
dominately with the blood from the vena cava,
but only a minor portion flows through the
lung, with the major portion entering the aorta
via the ductus arteriosus [10, 11, 14]. Thus the
lung is poorly perfused being in a side branch
of the circulation. In the fetal lamb over 70%
of the entire pulmonary artery flow goes
through the ductus arteriosus [11]. Kidney and
liver are proportionately less perfused than in
the adult [10]. In the mature fetal lamb follow-
ing the onset of respiration after birth the pul-
monary perfusion increases 3 to 10 fold [11]
with the pulmonary resistance falling to 1/20
to 1/50 the original value [10]. Frequently the
ductus venosus remains patent temporarily
after birth, particularly in prematurity, so that
the circulation may bypass the liver [11]. These
circulatory relationships may explain the differ-
ence in the concentrations of bupivacaine in the
lungs of Fetus M and J. Fetus M was a mature
fetus breathing spontaneously for 20 minutes
postpartum; whereas, in Fetus J in the 24th
week of gestation no spontaneous respiration
occurred. A high organ concentration would
require good perfusion. BENOWITZ et al [2]
found that after I. V. injection of local anesthe-
tics the lung assumes a sort of buffer function
and absorbs up to 75% of the dose. An impor-
tant consideration is that the lung takes up the
entire output of the right heart, which situation
existed in Fetus M following the onset of
breathing and the probable closure of the fora-
men ovale, but not in Fetus J.
In animal experiments SJÖSTRAND and WIDMAN
[15] in rabbits also found a significantly high
concentration of bupivacaine in the lung es-
pecially with an acidotic pH. In Fetus M there
are several indicators for the existence of an
acidosis: the respiration is stimulated by the
rise in partial pressure of CO2 which shifts the
acidbase balance towards acidosis [14]. Fur-
thermore it has been known for some time that
even in normal deliveries the fetus experiences
an increase in acidosis toward the end of labor
[13]. In anencephaly additional factors enter:
according to LEMIRE [8] in most ancephalic
fetuses the lungs are hypoplastic and there is
a significant lack of surfactant. This prompts
alveolar collapse, pulmonary edema and distur-
bances in microcirculation. Likewise the cere-
bral dysfunction of an ancephalic infant pro-
motes acidosis because of disturbed respiratory
function. This acidosis in initially metabolic but
increasingly in Fetus M became respiratory,
i. e., the lung tissue becomes increasingly acid
in comparison to blood.
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For technical reasons no blood gas analysis on up a good part of the body weight, any decrease^
the fetuses could be carried out and conse- in uptake of the local anesthetic into the fat
quently our discussion and conclusions are tissue leads to markedly higher blood levels
somewhat limited. The cationic form in which and thus to higher concentrations in the other
bupivacaine occurs during the initial mild meta- organs. In Fetus M the concentration in the fat
bolic acidosis primarily leads to its increased was low — another indication for acidosis.
binding on the negative charged phospholipids . .
at the surface of the reticuloendothelial cells. The concentration m the kidneys of both fetus-
During the increasing respiratory acidosis es was ' dlffefent fr™ *!? * ?l
which resulted ultimately in the death of Fetus ?rSans such as sPleen'fU b^dder and ^ mus.
from asphyxia an increasing acidity of the fn comparison the rabbits, they were distinctly
intracellular space ensues with a resulting in- ^^ AV^n assumPtlons for th* hver>
crease in extra/intracellular pH gradient. This *he ^ duced blo°d ^  to 'hese orSans dufnS
leads to an intracellular accumulation because fetal llf* may play a role No comparison data
the intracellular ionized molecule is unable to are available for spleen, thymus and gall blad-
leave this space. KENNEDY et al [7] have identi- de,r- Th,e concentration in the gall bladder is
fied this effect. In Fetus J a different situation relatively high, presumably because of the ex-
prevails. Because the circulation remains de fac- cretion of bupivacaine by the liver into the bile
to in an intrauterine pattern the lung concentra- as has been Ascribed by other authors [4, 6].
tion remains correspondingly low. The assump-
 The study of SJOSTOAND and WlDMAN [15]
tion of an acidosis m Fetus M corresponds with
 shows that the regults were in SQme afeas the
tte relatively high level in the myocardium.
 same> whue th differed in others Qf . .
The strongest stimulus for dilatation of the ^^
 be that the hi h yalues in the j
coronary vessels is hypoxia so that a increased
 of Fetus M corresponds to the values in rabbit
perfusion during asphyxia may be assumed, j
 wkh addotic R
WIDMAN [19] reported m patients with acidosis
and low cardiac output initially high concentra-
 On the other hand, it is noteworthy that in
tions in the heart which otherwise did not occur, both fetuses, liver and kidney concentrations
The liver values are only elevated to twice that
 were distinctly lower than reported by
of the blood levels in both fetuses. SJÖSTRAND and WIDMAN [15]. This might have
The fetal liver is not yet fully equipped for its explanation in the different specific anatomi-
metabolism of local anesthetics, thus the agent cal relations in the human fetus. The findings
accumulates [3]. Compared with the results of for the concentrations in brain, muscle and fat
SJÖSTRAND and WIDMAN [15] our values were tissue were largely comparable; for the other
noticably lower. Possibly this expresses the low- organs comparison values were not available.
er perfusion in conditions of fetal circulation. „,.
 14. ., , ,These results may contribute to better under-
The concentration in the brain is low in both standing of the metabolic processes when using
fetuses corresponding with results of bupivacaine for obstetric epidural anesthesia.
SJÖSTRAND and WIDMAN [15] and is about the Additional investigations on the role of the lung
same as the blood concentration. SJÖSTRAND in the pharmacokinetics of local anesthetics are
and WIDMAN in their rabbit experiments with desirable. For the clinical use of epidural anal-
normal and acidotic pH demonstrated that the gesia during delivery, results corroborate fur-
concentration in the fatty tissue with acidotic ther the importance of avoiding fetal acidosis
pH was only 40% of the concentration during before and during the use of such analgesia,
normal pH. This is an important factor for the This requires accurate fetal monitoring with
increased blood level during acidosis. Because cardiotocography and pH measurements dur-
the fat tissue together with the muscles makes ing and after epidural analgesia.
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Summary
The concentration of bupivacaine in organs of non-
viable human fetuses after obstetrical epidural analgesia
in customary doses was investigated. The concentrations
were determined with a gas Chromatograph.
The material consisted of a fetus who died following
termination in the 24th week of pregnancy three minutes
after birth without spontaneous respiration. The other
fetus was born maturely in the 40th pregnancy week
with anencephaly who lived 20 minutes following initial
spontaneous respiration.
Most noteworthy were the increased concentrations in
the liver indicating the important metabolic function of
the liver for the metabolism of bupivacaine in the fetus.
Further a very high pulmonary concentration was found
in the mature fetus. Even though blood gases analysis
were not performed we conclude that:
1. the lung is the best perfused organ after birth and
onset of spontaneous respiration because of the clo-
sure of the ductus arteriosus.
2. because of the increasing agonal respiratory acid-
osis, bupivacaine accumulates in the lung, the organ
from which the acidosis originates. Also, the ionized
form the bupivacaine is unable to leave the intra-
cellular space.
For the clinical use of epidural analgesia during delivery,
these results constitute an important indication for
avoiding fetal acidosis before and during the action of
such analgesia. This mandates strict and continuous
fetal monitoring. Our results in agreement with other
authors show that during fetal acidosis and simultaneous
administration of bupivacaine the fetal distress may be
potentiated by an accelerated transfer of the anesthetic
agent into the fetal placental space. Under normal condi-
tions one may assume that this technique of analgesia
has a positive effect on the fetus because of the improved
placental perfusion. These results are intended to serve
toward an improved understanding of the metabolic
processes during the use of bupivacaine for obstetric
epidural analgesia. In our opinion the results do not
mitigate against the clinical use of epidural analgesia for
obstetrical indications.
Keywords: Epidural analgesia, fetal medication, local anesthesia, obstetrical analgesia.
Zusammenfassung
Die Konzentration von Bupivacain in fetalen Organen bei
geburtshilflicher Epiduralanalgesie
Organkonzentrationen von Bupivacain bei nicht lebens-
fähigen menschlichen Feten nach geburtshilflicher Epi-
duralanalgesie in üblicher Dosierung wurden untersucht.
Die Konzentrationswerte wurden mit Hilfe einer gas-
chromatographischen Methode gefunden.
Es handelte sich um einen Feten, der nach Abruptio in
der 24. Schwangerschaftswoche 3 Minuten post partum
verstarb, ohne vorher zu atmen. Außerdem lag ein ausge-
tragener Fet in der 40. Schwangerschaftswoche mit An-
enzephalie vor, der nach Geburt spontan atmete und
nach 20 Minuten an seiner Asphyxie verstarb.
An besonders auffalligen Werten sind die erhöhten Le-
berkonzentrationen beider Feten erwähnenswert: Sie zei-
gen die wichtige metabolische Funktion der Leber für
die Verstoffwechselung von Bupivacain beim Feten an.
Außerdem zeigte sich eine sehr hohe Lungenkonzentra-
tion von Bupivacain beim ausgetragenen Feten in der
40. Schwangerschaftswoche. Mit einer gewissen Ein-
schränkung wegen des Fehlens von Blutgasanalysen
kann aus diesem Ergebnis gefolgert werden:
1. Die Lunge ist das am stärksten durchblutete Organ
nach der Geburt durch den Verschluß des Ductus
arteriosus nach dem Einsetzen der Spontanatmung.
2. Durch die zunehmende respiratorische Azidose im
Finalstadium kommt es zu einer Anreicherung von
Bupivacain in der Lunge, dem Ort der Azidoseent-
stehung. Hierbei kann die dort ionisierte Form von
Bupivacain den intrazellulären Raum nicht mehr
verlassen.
Für die klinische Anwendung der Epiduralanalgesie un-
ter der Geburt bedeuten diese Untersuchungsergebnisse
einen wichtigen Hinweis zur Vermeidung fetaler Azido-
sen vor und während der Wirkung einer solchen Analge-
sieform. Hierfür ist ein striktes kontinuierliches fetales
Monitoring indiziert. Unsere Ergebnisse zeigen nämlich
auch, daß — in Übereinstimmung mit anderen Autoren
— bei Annahme einer fetalen Azidose und gleichzeitiger
Applikation von Bupivacain eine Potenzierung der Be-
einträchtigung des Feten durch einen Sog des Lokalan-
aesthetikum in den fetoplazentaren Bereich eintritt.
Gleichwohl ist unter normalen Umständen davon auszu-
gehen, daß durch diese Analgesieform eher positive
Effekte auf den Feten durch eine verbesserte plazentare
Perfusion entstehen. Unsere Untersuchungsergebnisse
sollen — neben den dargelegten Hinweisen für das klini-
sche Verhalten — einem besseren Verständnis der Stoff-
wechselvorgänge bei Anwendung von Bupivacain zur
geburtshilflichen Epiduralanalgesie dienen. Eine generel-
le Kritik an der klinischen Anwendung der Epidural-
analgesie zur geburtshilflichen Schmerztherapie ist unter
den genannten Vorbehalten aus unseren Ergebnissen
nicht abzuleiten.
Schlüsselwörter: Epiduralanalgesie, fetale Medikamentenbelastung, geburtshilfliche Analgesie, Lokalanästhesie.
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Resume
Concentration de bupivacaine dans les organes fotatix au
cours de l'analgesie peridurale en obstetrique
On a determine les concentrations de bupivacaine dans
les organes de foetus humains non viables apres analgesie
peridurale obstetricale aux doses habituelles. Les
concentrations ont 6te obtenues par Chromatographie
en phase gazeuse.
Les prelevements provenaient d'un foetus decede trois
minutes apres la naissance, dans la 24eme semaine de
gestation, sans respiration spontanee. L'autre foetus etait
un anencephale ne a terme, dans la 40eme semaine, qui
a vecu 20 minutes apres la respiration initiale spontanae.
Les concentrations hepatiques augmentees sont les plus
remarquables, elles indiquent une importante fonction
metabolique du foie pour le metabolisme de la bupiva-
caine chez le foetus. En outre, on a trouve une concentra-
tion pulmonaire tres elev6e chez le foetus mature. Et bien
que nous n'ayons pas d'analyse des gaz du sang, nous
concluons que:
1. Le poumon est 1'organe le mieux perfuse apres la
naissance et le debut de la respiration spontanee en
raison de la fermeture du canal arteriel.
2. En raison de l'accroissement de l'acidose respiratoire
agonique, la bupivacaine s'accumule dans les pou-
mons, organe au niveau duquel l'acidose se produit.
Egalement, la forme ionisee de la bupivacaine est
incapable de sortir de Tespace intra-cellulaire.
En ce qui concerne Putilisation clinique de l'analgesie
peridurale au cours du travail, ces resultats constituent
un argument important pour eviter une acidose foetale
avant et pendant Faction d'une teile analgesie. L'analge-
sie peridurale impose un monitoring foetal strict et conti-
nu. Nos resultats en accord avec ceux des autres auteurs
montrent qu'au cours d'une acidose foetale avec injection
simultanee de bupivacaine, une souffrance foetale peut
etre potentialisee par un transfert accelere de l'agent
anesthesique vers 1'espace foeto-placentaire. Lorsque les
conditions sont normales, on peut supposer que cette:
technique d'analgesie ait un effet positif sur le foetus en
raison d'une augmentation de la perfusion placentaire.
Ces resultats Visaient ä obtenir une meilleure comprehen-
sion des processus metaboliques pendant Putilisation de
bupivacaine lors de l'analgesie peridurale en obstetrique.
Selon nous, les resultats ne voiit pas contre 1'usage
clinique de l'analgesie peridurale pour des indications
obstetricales.
Mots-cles: Analgesie obstetricale, analgesie peridurale, anesthesie locale, medication foetale.
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